Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Vienna, 1090, Austria.
Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Riyadh Province, Saudi Arabia.
Lancet Haematol. 2022 Aug;9(8):e605-e614. doi: 10.1016/S2352-3026(22)00184-3.
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem cell transplantations (HSCT) remains increasingly important, particularly because of the growing use of haploidentical HSCT. Compared with the strict recommendations on the suitability for unrelated donors, criteria for related donors allow for more discretion and vary between centres. In 2015, the donor outcome committee of the Worldwide Network for Blood and Marrow Transplantation (WBMT) proposed consensus recommendations of suitability criteria for paediatric and adult related donors. This Review provides updates and additions to these recommendations from a panel of experts with global representation, including the WBMT, the European Society for Blood and Marrow Transplantation donor outcome committee, the Center for International Blood and Marrow Transplant Research donor health and safety committee, the US National Marrow Donor Program, and the World Marrow Donor Association, after review of the current literature and guidelines. Sections on the suitability of related donors who would not qualify as unrelated donors have been updated. Sections on communicable diseases, clonal haematopoiesis of indeterminate potential, paediatric aspects including psychological issues, and reporting on serious adverse events have been added. The intention of this Review is to support decision making, with the goal of minimising the medical risk to the donor and protecting the recipient from transmissible diseases.
相关供者对全球异基因造血干细胞移植(HSCT)数量不断增加的贡献变得越来越重要,特别是由于单倍体 HSCT 的应用日益增加。与对无关供者的严格适用性建议相比,相关供者的标准允许更多的自由裁量权,并在中心之间有所不同。2015 年,全球血液和骨髓移植网络(WBMT)的供者结果委员会提出了适合儿科和成人相关供者的适用性标准的共识建议。本综述由具有全球代表性的专家小组(包括 WBMT、欧洲血液和骨髓移植学会供者结果委员会、国际血液和骨髓移植研究中心供者健康和安全委员会、美国国家骨髓捐赠者计划和世界骨髓捐赠者协会)在审查当前文献和指南后,对这些建议进行了更新和补充。不适合作为无关供者的相关供者的适用性部分已被更新。增加了关于传染病、不确定潜能的克隆性造血、包括心理问题在内的儿科方面,以及严重不良事件报告的章节。本综述的目的是支持决策制定,目标是将供者的医疗风险降至最低,并防止受者感染可传播疾病。